GlassScriptPhysician profile
Michael Mcmullen
NPI 1528485026
$10,874.00
in general payments reported to CMS, 2019-2025
14 companies · $343 in 2025
The $343 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,070 · 2022: $3,932 · 2023: $4,164 · 2024: $365 · 2025: $343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,200 · Travel and Lodging: $1,568 · Food and Beverage: $1,105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,200.00 |
| Travel and Lodging | $1,567.78 |
| Food and Beverage | $1,104.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $8,920.39 | 2021-2024 | |
| Otsuka America Pharmaceutical, INC. | $431.68 | 2021-2025 | Rexulti |
| Lundbeck LLC | $377.11 | 2021-2025 | Rexulti |
| Takeda Pharmaceuticals U.S.A., INC. | $278.55 | 2021-2025 | Trintellix |
| Indivior INC. | $244.32 | 2021-2025 | Sublocade |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $203.33 | 2021-2025 | Caplyta |
| Biohaven Pharmaceutical Holding Company LTD. | $158.13 | 2022 | |
| Vanda Pharmaceuticals INC. | $69.84 | 2024 | Fanapt |
| Teva Pharmaceuticals USA, INC. | $58.91 | 2024-2025 | Uzedy |
| Alkermes, INC. | $48.08 | 2022 | |
| Supernus Pharmaceuticals, INC. | $35.80 | 2022 | |
| Abbott Laboratories | $19.92 | 2022 | |
| Almatica Pharma LLC | $15.40 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $12.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mcmullen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.